FDA Approves Keytruda for Non-Small Cell Lung Cancer

FRIDAY, Oct. 2, 2015 — The U.S. Food and Drug Administration on Friday approved an immunotherapy drug for the treatment of advanced non-small cell lung cancer.
Keytruda (pembrolizumab) can be used to treat advanced non-small cell lung cancer in…
Source: Topamax